Comparing the current results to its competitors, Zomedica reported Revenue increase in the 1 quarter 2026 by 32.42 % year on year. The sales growth was above Zomedica 's competitors' average revenue growth of 6.88 %, achieved in the same quarter.
Zomedica 's Comment on Competition and Industry Peers
The company operates in multiple markets with various competitors. In the diagnostic market, competitors include Idexx Laboratories, Inc., Antech Diagnostics (a unit of Mars Inc.), Heska Corporation (a unit of Mars Inc.), Bionote USA Inc., Zoetis Inc. and its wholly owned subsidiary Abaxis, Inc., and Parasight System Inc. In the shock-wave market, competitors are Companion Animal Health (a division of LiteCure, LLC), K-Laser, Summus Medical Laser, LLC, ELvation Medical GmbH (sourced from Richard Wolf in Germany), and Curative Sound. Assisi products compete with Respond Systems Incorporated, which produces Pulsing Electro Magnetic Therapy products. In the veterinary ultrasound equipment market, competitors include Sound (a division of Antech) and Universal Imaging. For digital microscopy systems, competitors include Zoetis’ Imagyst™, Heska’s Element AIM™, and Idexx’ Digital Cytology™ inVue Dx platform. Many of these competitors possess greater financial, technical, and human resources, as well as more experience in the development, manufacture, regulation, and commercialization of animal diagnostics and medical devices.
Elanco Animal Health Incorporated Share Performance
+42.39%
One Year
Elanco Animal Health Incorporated
Profile
Elanco Animal Health Inc operates on a business model that focuses on the development, manufacturing, and marketing of veterinary products and services. They aim to provide innovative solutions for animal health and well-being, offering a range of products including medicines, vaccines, and feed additives. Elanco serves both companion animals and food-producing animals, catering to the diverse needs of veterinarians, farmers, and pet owners worldwide.
Zoetis Inc operates as a global animal health company, offering a comprehensive range of medicines, vaccines, diagnostics, and services for both livestock and companion animals. Their business model emphasizes innovation in research and development to improve animal health, coupled with strong customer support, educational resources, and targeted solutions for veterinarians, livestock producers, and pet owners around the world.
Trupanion Inc is a pet insurance company that follows a subscription-based business model. They provide coverage for veterinary medical expenses incurred by pets, offering a comprehensive insurance plan that reimburses a high percentage of eligible costs. Their business is reliant on pet owners paying regular monthly premiums in exchange for financial protection for their pets' health needs.
Sources:
Zomedica Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Zomedica Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
